{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:29:57Z","timestamp":1787840997806,"version":"build-2784847793"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is a gradually worsening neurodegenerative condition marked by the deterioration of dopaminergic neurons, motor dysfunction, and mitochondrial dysfunction. Trans-chalcone, a natural flavonoid, has shown promise in various disease models because of its antioxidant and anti-inflammatory features. This study investigates the neuroprotective effects of transchalcone in a rat model of PD, focusing on its impact on the activation levels of AMP-activated protein kinase (AMPK) signaling pathway, sirtuin1 (SIRT1) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1\u03b1) proteins, and mitochondrial-inflammatory responses. Male Sprague Dawley rats were allocated into five groups Control, Control plus transchalcone, PD, PD plus transchalcone, PD plus compound-C, and PD plus Compound-C and trans-chalcone. PD was induced using intranigral 6-hydroxydopamine injection. Trans-chalcone (100 \u03bcg\/kg) and compound-C (20 mg\/kg) were intraperitoneally administered daily for 4 weeks in PD rats. Motor function was assessed using rota-rod and grid tests. Striatal dopamine and cytokines (interleukin 1-beta [IL-1 \u03b2], IL-10) and p65-nuclear factor kappa-B (NF-\u03baB) levels were measured with enzyme-linked immunosorbent assay. Mitochondrial function was evaluated by fluorometric techniques. The expression of phosphorylated AMPK, PGC-1\u03b1, and SIRT1 was analyzed by Western blotting. Trans-chalcone treatment significantly improved motor function, evidenced by increased latency to fall in the rota-rod test and recovered traversal time in the grid test. It also restored dopamine levels, enhanced mitochondrial function (reduced reactive oxygen species levels, increased membrane potential, and adenosine triphosphate production), normalized cytokines (IL-1 \u03b2, IL-10) and p65-NF-\u03baB, and upregulated the proteins expression in rats with PD. Inhibition of AMPK activity with compound-C suppressed the neuroprotective impacts of trans-chalcone, highlighting the contribution of AMPK signaling pathway in its mechanism of action. Neuroprotective and mitoprotective impacts of trans-chalcone were mostly mediated through the activation of AMPK-SIRT1-PGC1\u03b1 pathway. These results indicate that trans-chalcone could be a promising therapeutic agent for PD, warranting further investigation to assess its efficacy and safety in human patients.<\/jats:p>","DOI":"10.4103\/ejpi.ejpi-d-24-00083","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T01:00:28Z","timestamp":1733446828000},"page":"312-320","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Neuroprotective Role of Transchalcone in Parkinson\u2018s Disease through AMP-activated Protein Kinase-mediated Signaling Pathway"],"prefix":"10.4103","volume":"67","author":[{"given":"Yao","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Neurology, Harbin 242 Hospital, Harbin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaik Althaf","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki Mayudh","family":"Alrubie","sequence":"additional","affiliation":[{"name":"Department of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated Hospital of Yunnan University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"R1-20241206","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease:Mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci"},{"key":"R2-20241206","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1097\/MS9.0000000000001142","article-title":"Parkinson's disease updates:Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment","volume":"85","author":"Prajjwal","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"R3-20241206","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/antiox9080647","article-title":"Mitochondrial dysfunction, oxidative stress, and neuroinflammation:Intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"R4-20241206","doi-asserted-by":"crossref","first-page":"e12443","DOI":"10.1590\/1414-431x2023e12443","article-title":"Effect of silibinin and trans-chalcone in an Alzheimer's disease-like model generated by insulin amyloids","volume":"56","author":"Omidi-Shahsavandi","year":"2023","journal-title":"Braz J Med Biol Res"},{"key":"R5-20241206","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/molecules25122907","article-title":"The antioxidant, anti-inflammatory, and neuroprotective properties of the synthetic chalcone derivative AN07","volume":"25","author":"Chen","year":"2020","journal-title":"Molecules"},{"key":"R6-20241206","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/13813455.2020.1764045","article-title":"trans-chalcone inhibits transforming growth factor-\u03b21 and connective tissue growth factor-dependent collagen expression in the heart of high-fat diet-fed rats","volume":"128","author":"Karimi-Sales","year":"2022","journal-title":"Arch Physiol Biochem"},{"key":"R7-20241206","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/ejpi.EJPI-D-24-00006","article-title":"Protective effects of trans-chalcone on myocardial ischemia and reperfusion challenge through targeting phosphoinositide 3-kinase\/Akt-inflammosome interaction","volume":"67","author":"Wang","year":"2024","journal-title":"J Physiol Investig"},{"key":"R8-20241206","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK:Guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R9-20241206","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jamcollsurg.2019.12.029","article-title":"Cardiac dysfunction after burn injury:Role of the AMPK-SIRT1-PGC1\u03b1-NFE2L2-ARE pathway","volume":"230","author":"Wen","year":"2020","journal-title":"J Am Coll Surg"},{"key":"R10-20241206","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab"},{"key":"R11-20241206","doi-asserted-by":"crossref","first-page":"107705","DOI":"10.1016\/j.pharmthera.2020.107705","article-title":"PPAR\u03b3\/PGC1\u03b1 signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders","volume":"219","author":"Jamwal","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R12-20241206","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10787-022-01125-5","article-title":"SIRT1 pathway in Parkinson's disease:A faraway snapshot but so close","volume":"31","author":"Batiha","year":"2023","journal-title":"Inflammopharmacology"},{"key":"R13-20241206","first-page":"120","article-title":"AMPK signaling pathway as a potential therapeutic target for Parkinson's disease","volume":"14","author":"Athari","year":"2024","journal-title":"Adv Pharm Bull"},{"key":"R14-20241206","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson's disease \u2013A key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol Neurodegener"},{"key":"R15-20241206","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/ph15070847","article-title":"Chalcones as potential ligands for the treatment of Parkinson's disease","volume":"15","author":"Kr\u00f3licka","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"R16-20241206","doi-asserted-by":"crossref","first-page":"115788","DOI":"10.1016\/j.biopha.2023.115788","article-title":"Flavonoids:Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson's disease","volume":"168","author":"A\u00e7ar","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R17-20241206","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/jmf.2017.4078","article-title":"Beneficial effects of flavonoids against Parkinson's disease","volume":"21","author":"Jung","year":"2018","journal-title":"J Med Food"},{"key":"R18-20241206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pneurobio.2018.09.003","article-title":"New insights into the complex role of mitochondria in Parkinson's disease","volume":"177","author":"Gr\u00fcnewald","year":"2019","journal-title":"Prog Neurobiol"},{"key":"R19-20241206","doi-asserted-by":"crossref","first-page":"e00292","DOI":"10.1016\/j.neurot.2023.10.002","article-title":"Mitochondrial dysfunction in neurodegenerative disorders","volume":"21","author":"Klemmensen","year":"2024","journal-title":"Neurotherapeutics"},{"key":"R20-20241206","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exp Neurobiol"},{"key":"R21-20241206","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fcell.2019.00154","article-title":"What is nuclear factor kappa B (NF-\u03baB) doing in and to the mitochondrion?","volume":"7","author":"Albensi","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"R22-20241206","first-page":"216298","article-title":"Transcriptional factor NF-\u03baB as a target for therapy in Parkinson's disease","author":"Flood","year":"2011","journal-title":"Parkinsons Dis 2011"},{"key":"R23-20241206","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"R24-20241206","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1038\/s41598-020-66493-w","article-title":"Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson's disease rat model","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"key":"R25-20241206","doi-asserted-by":"crossref","first-page":"112610","DOI":"10.1016\/j.nut.2024.112610","article-title":"Plant-derived compounds as potential neuroprotective agents in Parkinson's disease","volume":"130","author":"Niu","year":"2024","journal-title":"Nutrition"},{"key":"R26-20241206","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/jcph.1008","article-title":"Repeated-dose oral N-acetylcysteine in Parkinson's disease:Pharmacokinetics and effect on brain glutathione and oxidative stress","volume":"58","author":"Coles","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"R27-20241206","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/ijms23010398","article-title":"Metformin repurposing for parkinson disease therapy:Opportunities and challenges","volume":"23","author":"Agostini","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R28-20241206","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1:A long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R29-20241206","doi-asserted-by":"crossref","first-page":"871357","DOI":"10.3389\/fcell.2022.871357","article-title":"PGC-1a-mediated mitochondrial quality control:Molecular mechanisms and implications for heart failure","volume":"10","author":"Chen","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"R30-20241206","doi-asserted-by":"crossref","first-page":"104846","DOI":"10.1016\/j.yexmp.2022.104846","article-title":"The PI3K-AKT pathway:A plausible therapeutic target in Parkinson's disease","volume":"129","author":"Goyal","year":"2023","journal-title":"Exp Mol Pathol"},{"key":"R31-20241206","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fnagi.2019.00313","article-title":"SIRT3 regulation of mitochondrial quality control in neurodegenerative diseases","volume":"11","author":"Meng","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"R32-20241206","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.3390\/ijms19102973","article-title":"Role of mitogen activated protein kinase signaling in Parkinson's disease","volume":"19","author":"Bohush","year":"2018","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Physiological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ejpi.EJPI-D-24-00083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:39:16Z","timestamp":1787837956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ejpi.EJPI-D-24-00083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ejpi.ejpi-d-24-00083","relation":{},"ISSN":["2950-6344","2950-6352"],"issn-type":[{"value":"2950-6344","type":"print"},{"value":"2950-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-08-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}